PTGS2 and colonic neoplasm: Additionally, overexpression of XRCC5attenuated the suppression effect of celecoxib (a COX-2 inhibitor) on colon cancer cell proliferation, which implicates that XRCC5 affects colon cancer cell proliferation via regulating COX-2.